Veronica Codullo
Overview
Explore the profile of Veronica Codullo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
83
Citations
1085
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zanframundo G, Codullo V, Cavagna L
Clin Exp Rheumatol
. 2025 Feb;
43(2):184-185.
PMID: 39977008
No abstract available.
2.
Cacciapaglia F, De Angelis R, Ferri C, Bajocchi G, Bellando-Randone S, Bruni C, et al.
J Rheumatol
. 2025 Jan;
PMID: 39814435
Objective: Bosentan (BOS) is approved for treating pulmonary arterial hypertension (PAH) and preventing digital ulcers (DU) in systemic sclerosis (SSc). Our study aimed to evaluate whether BOS prescribed for DU...
3.
Bottazzi F, Milanesi A, Codullo V, Messina A, Montecucco C, Delvino P
Clin Exp Rheumatol
. 2024 Dec;
PMID: 39680078
No abstract available.
4.
Talarico R, Marinello D, Palla I, Cannizzo S, Galetti I, Farrington S, et al.
J Scleroderma Relat Disord
. 2024 Nov;
:23971983241269109.
PMID: 39544904
Objective: To optimise the organisation of care and encourage the adoption of good clinical practices, the RarERN Path methodology was designed within ERN ReCONNET. The aim of our work was...
5.
Iannone C, Pellico M, Morlacchi L, Rossetti V, Vicenzi M, Beretta L, et al.
Rheumatology (Oxford)
. 2024 Sep;
PMID: 39298492
Objectives: Lung transplantation (LuTx) is a life-saving intervention for Systemic Sclerosis (SSc) patients with end-stage lung disease. The aim of this study was to evaluate patients' survival and LuTx outcomes...
6.
Day J, Kushlaf H, Tarvin S, Cavagna L, Codullo V, Shinjo S, et al.
Curr Rheumatol Rep
. 2024 Aug;
26(12):414-420.
PMID: 39215900
No abstract available.
7.
Esposito G, Fassio F, Girardi D, Picasso E, Meloni F, Montini S, et al.
Vaccine
. 2024 Aug;
42(23):126208.
PMID: 39154513
Background: Infection by SARS-CoV2 has become a challenge, especially for immunocompromised patients who show a weaker humoral response to COVID-19 vaccine. Tixagevimab+cilgavimab (Evusheld) is a combination of human monoclonal antibodies...
8.
Orlandi M, Bellando-Randone S, De Angelis R, Ferri C, Giuggioli D, Cacciapaglia F, et al.
Eur J Intern Med
. 2024 Aug;
130:130-136.
PMID: 39147653
Objectives: The current knowledge about the role of comorbidities in systemic sclerosis (SSc) is limited. Therefore, the aim of this study was to evaluate the prevalence of comorbidities and their...
9.
Lepri G, Di Battista M, Codullo V, Bonomi F, Sulis A, Guiducci S, et al.
Clin Exp Rheumatol
. 2024 Jul;
42(8):1517-1528.
PMID: 39058484
Systemic sclerosis (SSc) is a rare and chronic connective tissue disease of unknown aetiology and characterised by three main pathogenetic events represented by endothelial damage, inflammation with activation of the...
10.
Andreoli L, Gerardi M, Gerosa M, Rozza D, Crisafulli F, Erra R, et al.
RMD Open
. 2024 Apr;
10(2).
PMID: 38663885
Objectives: To investigate pregnancy outcomes in women with autoimmune rheumatic diseases (ARD) in the Italian prospective cohort study P-RHEUM.it. Methods: Pregnant women with different ARD were enrolled for up to...